Table 3 Factors affecting disease free survival among studied cases
Variables | 1 year | 5 years | Test of significance | P value |
|---|---|---|---|---|
Gender | ||||
Male | 95% | 69.7% | 2.917 | 0.088 |
Female | 90% | 36.4% | ||
Age | ||||
≤ 60 | 90.9% | 56.5% | 0.033 | 0.856 |
> 60 | 93.8% | 52.4% | ||
HCVseropositivity | ||||
Negative | 88.1% | 54.6% | 0.005 | 0.942 |
Positive | 100% | 53% | ||
B symptoms | ||||
Absent | 86.5% | 52% | 0.237 | 0.626 |
Present | 100% | 57.8% | ||
BM infiltration (N = 93) | ||||
No | 90.5% | 54.3% | 0.054 | 0.816 |
Yes | 100% | 50% | ||
Hans classification | ||||
GC | 100% | 100% | 3.704 | 0.054 |
Non-GC | 90.6% | 46.6% | ||
IPI risk | ||||
Low and low intermediate | 92% | 61.9% | 0.462 | 0.497 |
High intermediate and high | 92.3% | 38.7% | ||
P53 expression (N = 85) | ||||
No over expression | 96% | 49.4% | 0.04 | 0.841 |
Over expression | 76.2% | 50.8% | ||
Double expresser | ||||
No | 90.8% | 56% | 1.987 | 0.159 |
Yes | 100% | 50% | ||
Triple expresser | ||||
No | 92% | 63.7% | 1.129 | 0.288 |
Yes | – | – | ||
PD-L1 expression | ||||
Low | 100% | 84.8% | 10.806 | 0.001* |
High | 85.4% | 29% | ||